ArticleAnnals of translational medicine2021

PIK3CA mutation confers resistance to chemotherapy in triple-negative breast cancer by inhibiting apoptosis and activating the PI3K/AKT/mTOR signaling pathway.

Huayu Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.